Drug
Cadefrecitinib clinical trials
Also written GLPG3667.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
8 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses cadefrecitinib is read from its arms, and is right about nine times in ten.
Testing it · 8
- A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus ErythematosusCompletedPhase 2Lakefront Biotherapeutics NVNCT05856448Written as GLPG3667
- A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With DermatomyositisCompletedPhase 2Lakefront Biotherapeutics NVNCT05695950Written as GLPG3667
- A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3667CompletedPhase 1Galapagos NVNCT04097938Written as GLPG3667 oral suspension
- Drug-drug Interaction Study with GLPG3667 and Itraconazole in Healthy SubjectsCompletedPhase 1Galapagos NVNCT05272683Written as GLPG3667
- Evaluation of Mass Balance and Absolute Bioavailability of GLPG3667CompletedPhase 1Lakefront Biotherapeutics NVNCT05335447Written as GLPG3667 capsule
- A Study to Evaluate How Well Single and Multiple Doses of GLPG3667 Are Tolerated in Healthy, Adult SubjectsCompletedPhase 1Galapagos NVNCT04976270Written as GLPG3667
- A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque PsoriasisCompletedPhase 1Galapagos NVNCT04594928Written as GLPG3667
- Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy SubjectsCompletedPhase 1Galapagos NVNCT04736927Written as GLPG3667
Codes
What other systems call cadefrecitinib · ClinicalTrials.gg INT017390
- UNII (FDA) NKX4HH6CWKCADEFRECITINIBConfirmed FDA, Wikidata
- Wikidata Q140528729cadefrecitinibConfirmed FDA, Wikidata
- NCI Thesaurus C224721CadefrecitinibOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | NKX4HH6CWK | CADEFRECITINIB | Confirmed FDA, Wikidata |
| Wikidata | Q140528729 | cadefrecitinib | Confirmed FDA, Wikidata |
| NCI Thesaurus | C224721 | Cadefrecitinib | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.